Kintor Pharmaceutical Ltd (HK:9939) has released an update.
Kintor Pharmaceutical Ltd has announced the receipt of the International Nomenclature Cosmetic Ingredient (INCI) designation for its product KX-826, a significant milestone that paves the way for its global launch in the functional cosmetics market. The INCI designation is a globally recognized standard for cosmetic ingredient labeling. However, the company cautions there is no guarantee of KX-826’s successful development or marketability.
For further insights into HK:9939 stock, check out TipRanks’ Stock Analysis page.